Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: during (1000)

Duodenal atresia - patient information

Description: A scan has shown that your baby may have a condition called duodenal atresia.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Duodenal-atresia-2828-PIL.pdf

Gastroschisis - patient information

Description: This factsheet has been designed to accompany the individualised discussions you will have about your care and the care of your
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Gastroschisis-2826-PIL.pdf

SETT Centre Clinical Theme Lead EOI 2024

Description: Southampton Emerging Therapies and Technologies (SETT) Clinical Theme Lead: Call for expressions of interest The University of Southampton NHS Fo
Url: /Media/Southampton-Clinical-Research/Downloads/SETT-Centre-Clinical-Theme-Lead-EOI-2024.pdf

Rifampicin and clindamycin for hidradenitis suppurativa in adults - patient information

Description: This factsheet explains what rifampicin and clindamycin are, how to take the medicines and the possible side effects.
Url: /Media/UHS-website-2019/Patientinformation/Skin/Rifampicin-and-clindamycin-for-hidradenitis-suppurativa-in-adults-3649-PIL.pdf

Going home after mesh removal surgery - patient information

Description: This factsheet explains what to expect after having mesh removal surgery, including what symptoms to look out for and when to
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Going-home-after-mesh-removal-surgery-3556-PIL.pdf

Finance and Performance Reports 2023-24 Month 2 May 2023

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Finance Report 2023-24 Month 2 9.2 Ian
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Finance-and-Performance-Reports-2023-24-Month-2-May-2023.pdf

Lung stereotactic ablative body radiotherapy (SABR) - patient information

Description: This factsheet explains what lung stereotactic ablative body radiotherapy (SABR) is and what to expect during treatment.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lung-stereotactic-ablative-body-radiotherapy-SABR-2091-PIL.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day-Mod-BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day Modified) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplatin-Etoposide (5 day-Mod-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-Mod-BEP-Ver1.2.pdf

Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day Modified) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 d
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-Mod-BEP-Ver1.2.pdf

InP-PAM-(cycles 5-6) v1

Description: Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol i
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

111 to 120 of 554

Previous … 10 11 12 13 14 … Next